KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioInterest Coverage RatioInvested CapitalNet MarginReturn on AssetsReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Omega Healthcare Investors (OHI) Return on Sales (2016 - 2025)

Omega Healthcare Investors' Return on Sales history spans 15 years, with the latest figure at 0.57% for Q4 2025.

  • For Q4 2025, Return on Sales rose 15.0% year-over-year to 0.57%; the TTM value through Dec 2025 reached 0.52%, up 13.0%, while the annual FY2025 figure was 0.52%, 12.0% up from the prior year.
  • Return on Sales for Q4 2025 was 0.57% at Omega Healthcare Investors, down from 0.6% in the prior quarter.
  • Across five years, Return on Sales topped out at 0.78% in Q1 2022 and bottomed at 0.1% in Q3 2023.
  • The 5-year median for Return on Sales is 0.39% (2024), against an average of 0.37%.
  • The largest annual shift saw Return on Sales soared 67bps in 2022 before it crashed -62bps in 2023.
  • A 5-year view of Return on Sales shows it stood at 0.11% in 2021, then surged by 192bps to 0.32% in 2022, then decreased by -26bps to 0.24% in 2023, then soared by 76bps to 0.42% in 2024, then soared by 35bps to 0.57% in 2025.
  • Per Business Quant, the three most recent readings for OHI's Return on Sales are 0.57% (Q4 2025), 0.6% (Q3 2025), and 0.51% (Q2 2025).